Delivery Order SPE2DB25D3008-SPE2DB25FRCEW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $17,181.16. This firm fixed-price delivery order, which is not associated with any set-aside program, is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract is scheduled for completion by October 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order representing a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed-price contract valued at $8,590.58, with completion targeted for August 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 on August 19, 2025, for the supply of Ofev 150 mg capsules (60-count). This is a firm fixed price delivery order with a completion date of September 10, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This firm fixed-price delivery order, which is scheduled for completion by October 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ofev 150 mg capsules (60-count unit) with a ceiling value of $8,590.58. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ofev 150 mg capsules in a quantity of 60 units. This firm fixed-price delivery order, valued at $8,590.58, represents a non-competitive award and is scheduled for completion by September 22, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCEWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 under a firm fixed-price contract. This is a non-set-aside award issued as a child delivery order, with performance to be completed by June 24, 2025, and fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military healthcare operations. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, and medical devices across multiple therapeutic areas. The company's competitively awarded contracts with DLA demonstrate its capability to support critical military healthcare procurement requirements on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 6/2/25 |